Ares Villagrasa

ORCID: 0000-0003-0928-0427
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Alcohol Consumption and Health Effects
  • Liver Disease and Transplantation
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Alcoholism and Thiamine Deficiency
  • Cardiac, Anesthesia and Surgical Outcomes
  • Blood Pressure and Hypertension Studies
  • Diet and metabolism studies
  • Sepsis Diagnosis and Treatment
  • Gastroesophageal reflux and treatments
  • Malaria Research and Control
  • Hemodynamic Monitoring and Therapy
  • Neurological and metabolic disorders
  • Hepatitis Viruses Studies and Epidemiology
  • Pancreatitis Pathology and Treatment
  • Long-Term Effects of COVID-19
  • Folate and B Vitamins Research
  • Liver Diseases and Immunity
  • Renal and Vascular Pathologies
  • Drug-Induced Hepatotoxicity and Protection
  • Trauma and Emergency Care Studies
  • Organ Transplantation Techniques and Outcomes
  • Cerebrovascular and Carotid Artery Diseases

Vall d'Hebron Hospital Universitari
2021-2024

Vall d'Hebron Institut de Recerca
2021-2024

Universitat Autònoma de Barcelona
2021-2023

Hospital General de Granollers
2010-2022

The prevalence and impact of alcohol withdrawal syndrome (AWS) in patients with alcohol-associated hepatitis (AH) are unknown. In this study, we aimed to investigate the prevalence, predictors, management, clinical AWS hospitalized AH.A multinational, retrospective cohort study enrolling AH at 5 medical centres Spain USA was performed between January 1st, 2016 31st, 2021. Data were retrospectively retrieved from electronic health records. Diagnosis based on criteria use sedatives control...

10.1016/j.eclinm.2023.102046 article EN cc-by-nc-nd EClinicalMedicine 2023-06-22

Different patterns of liver injury have been reported in association with the SARS-CoV-2 vaccines. The aim this study was to describe a nationwide cohort patients SARS CoV-2 vaccine-induced injury, focusing on treatment and evolution after further booster administration. multicentre, retrospective-prospective study, including subjects who developed abnormal tests within 90 days administration vaccination. 47 cases were collected: 17 prime dose 30 booster. Age 57 years, (63.8%) female, 7...

10.1016/j.aohep.2024.101489 article EN cc-by-nc-nd Annals of Hepatology 2024-02-23

Abstract Background & Aims Alcohol‐related hepatitis (AH) encompasses a high mortality. AH might be concomitant event in patients with acute variceal bleeding (AVB). The current study aimed to assess the prevalence of AVB and compare clinical outcomes other alcohol‐related liver disease (ALD) phenotypes viral cirrhosis. Methods Multicentre, observational including 916 falling under next categories: ( n = 99), ALD cirrhosis actively drinking (d‐ALD) 285), abstinent from alcohol (a‐ALD)...

10.1111/liv.15606 article EN Liver International 2023-05-15

Liver injury has been widely described in patients with Coronavirus disease 2019 (COVID-19). We aimed to study the effect of liver biochemistry alterations, previous disease, and value elastography on hard clinical outcomes COVID-19 patients. conducted a single-center prospective observational 370 consecutive admitted for polymerase chain reaction (PCR)-confirmed pneumonia. Clinical laboratory data were collected at baseline parameters events recorded during follow-up. Transient [with...

10.1177/17562848211016567 article EN cc-by-nc Therapeutic Advances in Gastroenterology 2021-01-01

Study Purpose: To analyze the cardiovascular risk factors control and therapeutical inertia (TI) in a vascular unit. identify related to TI. Methods: Review VisualCor ® database, used as clinical record Vascular Risk Unit country hospital. We reviewed random sample of patients controlled unit with minimum 3 follow-up visits. Results: have studied 79 patients, average age 60.1 ± 12.6 years, 64.6% male, 64.5% diagnosis hypertension, 2.4 prescription drugs, 41.7% type 2 diabetes mellitus (DM2),...

10.1097/01.hjh.0000379885.18350.f3 article EN Journal of Hypertension 2010-06-01

ABSTRACT Human albumin solution (HAS) is a plasma-derived product used for wide variety of clinical indications, although only some these are supported by solid scientific evidence. Objectives The primary aim this study was to analyze the level evidence supporting indications which HAS at secondary care hospital. Secondary objectives were evaluate dosing appropriateness and perform subanalysis internal medicine department. Methods Retrospective, observational, multidisciplinary adults who...

10.1101/2022.08.23.22279130 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-08-24
Coming Soon ...